☰

Moumita Chatterjee, Ph.D. - Publications

Affiliations: 
2011 Department of Biological Sciences University of Delaware, Newark, DE, United States 
Area:
Cell Biology, Oncology
Tree Info Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Chatterjee M, Ben-Josef E, Robb R, Vedaie M, Seum S, Thirumoorthy K, Palanichamy K, Harbrecht M, Chakravarti A, Williams TM. Caveolae-Mediated Endocytosis is Critical for Albumin Cellular Uptake and Response to Albumin-Bound Chemotherapy. Cancer Research. PMID 28923854 DOI: 10.1158/0008-5472.Can-17-0604  0.486
2016 Williams TM, Chatterjee M, Robb R, Vedaie M, Seum S, Krishnan T, Kamalakanan P, Ben-Josef E, Chakravarti A. Abstract 405: Caveolin-1 expression mediates response to albumin-bound paclitaxel Cancer Research. 76: 405-405. DOI: 10.1158/1538-7445.Am2016-405  0.526
2016 Banerji B, Chatterjee M, Prodhan C, Chaudhuri K. Tripeptide consisting of benzyl protected di-cysteine and phenylalanine forms spherical assembly and induces cytotoxicity in cancer cells via apoptosis Rsc Advances. 6: 112667-112676. DOI: 10.1039/C6RA23911K  0.315
2015 Estrada-Bernal A, Chatterjee M, Haque SJ, Yang L, Morgan MA, Kotian S, Morrell D, Chakravarti A, Williams TM. MEK Inhibitor GSK1120212-Mediated Radiosensitization of Pancreatic Cancer Cells Involves Inhibition of DNA Double-Strand Break Repair Pathways. Cell Cycle (Georgetown, Tex.). 0. PMID 26505547 DOI: 10.1080/15384101.2015.1104437  0.413
2015 Bertino EM, Williams TM, Nana-Sinkam SP, Shilo K, Chatterjee M, Mo X, Rahmani M, Phillips GS, Villalona-Calero MA, Otterson GA. Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients. Clinical Lung Cancer. 16: 466-474.e4. PMID 26123189 DOI: 10.1016/J.Cllc.2015.05.004  0.319
2015 Chatterjee M, Ben-Josef E, Thomas DG, Morgan MA, Zalupski MM, Khan G, Andrew Robinson C, Griffith KA, Chen CS, Ludwig T, Bekaii-Saab T, Chakravarti A, Williams TM. Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer. Scientific Reports. 5: 10867. PMID 26065715 DOI: 10.1038/Srep10867  0.481
2015 Houghton PJ, Kurmasheva RT, Kolb EA, Gorlick R, Maris JM, Wu J, Tong Z, Arnold MA, Chatterjee M, Williams TM, Smith MA. Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane(®)) by the Pediatric Preclinical Testing Program (PPTP). Pediatric Blood & Cancer. 62: 1214-21. PMID 25809532 DOI: 10.1002/Pbc.25474  0.301
2015 Robb RN, Yang L, Chatterjee M, Saji M, Ringel M, Chakravarti A, Williams T. Abstract C31: Vemurafenib selectively radiosensitizes BRAF V600E mutant papillary and anaplastic thyroid carcinoma cells in vitro Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C31  0.392
2015 Chatterjee M, Vedaie M, Robb R, Seum S, Estrada-Bernal A, Krishnan T, Kamalakanan P, Lin C, Chakravarti A, Williams TM. Abstract B8: Caveolae-mediated endocytosis is critical for tumor cell response to nab-paclitaxel Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-B8  0.513
2014 Chatterjee M, Williams TM. Abstract 4702: Caveolin-1 confers a multi-modality therapy resistance phenotype in pancreatic cancer cells Cancer Research. 74: 4702-4702. DOI: 10.1158/1538-7445.Am2014-4702  0.506
2014 Williams T, Chatterjee M. Caveolin-1 Confers a Multimodality Therapy Resistance Phenotype in Pancreatic Cancer Cells International Journal of Radiation Oncology*Biology*Physics. 90: S367. DOI: 10.1016/J.Ijrobp.2014.05.1188  0.404
2011 Chatterjee M, Sequeira L, Jenkins-Kabaila M, Dubyk CW, Pathak S, van Golen KL. Individual rac GTPases mediate aspects of prostate cancer cell and bone marrow endothelial cell interactions. Journal of Signal Transduction. 2011: 541851. PMID 21776386 DOI: 10.1155/2011/541851  0.583
2011 Chatterjee M, van Golen KL. Farnesyl transferase inhibitor treatment of breast cancer cells leads to altered RhoA and RhoC GTPase activity and induces a dormant phenotype. International Journal of Cancer. Journal International Du Cancer. 129: 61-9. PMID 20824700 DOI: 10.1002/Ijc.25655  0.597
2011 Chatterjee M, van GK. P2-01-16: Dissecting the Cellular Mechanism of Induction and Sustenance of Dormancy by Rho GTPases in Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P2-01-16  0.508
2010 Pathak S, Chatterjee M, Dubyk CW, Sequeira L, Golen Kv. Abstract 2356: The role of the Rac GTPases in PC-3 prostate cancer cell diapadesis Cancer Research. 70: 2356-2356. DOI: 10.1158/1538-7445.Am10-2356  0.492
2010 Chatterjee M, Golen Kv. Abstract P4-06-10: Altered Activity of RhoA and RhoC GTPases Phosphorylate C-Jun N-Terminal Kinase and Induce Cellular Dormancy in Breast Cancer Cells Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P4-06-10  0.515
Show low-probability matches.